Group 1: Support for Local Industries - The bank focuses on supporting Qingdao's characteristic industries, such as marine economy and biomedicine, by identifying financing needs along the industrial chain and promoting steady growth in loan scales for major local industries [2] - The bank is expanding the application scenarios for sustainable development-linked loans and enhancing its carbon accounting platform to support the district's dual carbon goals [2] - Specific products like "Marine High-tech Loan" and "Port Supply Chain Finance" are being launched to support the marine industry [2] Group 2: Asset Quality Outlook - The bank anticipates a continued stable improvement in asset quality, with a decreasing non-performing loan (NPL) ratio [2] - Factors contributing to the decline in NPL ratio include restructuring the credit organization and business processes, which has led to better quality in newly issued loans [2] - Proactive risk assessment and increased efforts in managing existing risk clients have helped mitigate the occurrence of new NPLs [2]

Group 1: Industry Overview - The company is optimistic about the space computing industry, which involves deploying powerful computing capabilities in space, such as installing high-performance computing units on satellites to process vast amounts of data locally [2][3] - The global demand for computing power is experiencing exponential growth, driven by advancements in artificial intelligence, big data, and cloud computing [2][3] - Training an advanced AI model consumes electricity equivalent to the annual usage of thousands of households, highlighting the significant energy demands of large data centers [2][3] Group 2: Investment and Strategic Moves - In June 2025, the company invested 110 million RMB in Beijing Orbit Chuangguang Technology Co., Ltd., which focuses on deploying computing satellites in the Earth's dawn-dusk orbit to create space data centers [3][4] - Following the investment, the company's stake in Orbit Chuangguang increased from 19.30% to 28.68% after a capital increase of approximately 74.98 million RMB [6] Group 3: Technological Developments - Orbit Chuangguang's technology aligns with global trends in space computing, utilizing 24/7 solar power and advanced cooling technologies to address energy supply and heat dissipation challenges [4] - Recent advancements include the successful launch of the Starcloud-1 satellite by Starcloud, which conducted the first data center-level GPU operations in space [5] Group 4: Future Prospects and Challenges - The first experimental satellite "Chuangguang-1" has been developed but is yet to be launched due to various factors affecting launch schedules [7] - The company anticipates steady operational performance in 2025, with its specialty anti-counterfeiting paper and printing businesses being the main revenue contributors [8]

Group 1: Marketing Strategies - The Pharmaceutical Business Group focuses on becoming the "first brand" in pain management, leveraging the efficacy of Yunnan Baiyao products in this field [2] - Significant growth in aerosol and plaster products, with a comprehensive marketing strategy integrating various channels and scenarios [2][3] - Online sales increased by over 20%, with a total of 48.45 million visitors and 3.54 million consumers generated through e-commerce platforms, resulting in a GMV of 254 million yuan [3] Group 2: Dividend Distribution - For the 2024 fiscal year, the company will distribute a cash dividend of 11.85 yuan per 10 shares, totaling approximately 2.16 billion yuan, which is 90.09% of the net profit attributable to shareholders [4] - The total cash dividend for 2024, including special dividends, amounts to 23.98 yuan per 10 shares, with a total of 4.28 billion yuan [4][5] - In the first half of 2025, a cash dividend of 10.19 yuan per 10 shares will be distributed, totaling 1.82 billion yuan, representing 50.05% of the net profit for that period [5] Group 3: Future Product Development - The Health Products Business Group aims to be a leader in high-quality health products, focusing on oral care and expanding the product ecosystem [6] - Continuous enhancement of the oral product line and development of new products to strengthen market position [6] Group 4: R&D Planning - The company emphasizes innovation-driven development, focusing on both traditional Chinese medicine and innovative pharmaceuticals [7] - Ongoing projects include 16 major traditional Chinese medicine varieties and 37 development projects, with a focus on innovative drug development [8] - Short-term projects aim to enhance existing products, while long-term projects focus on innovative drug development aligned with social needs and technological advancements [8]

Group 1: Meeting Overview - The investor meeting was held on January 23, 2026, at the company's headquarters [1] - Participants included representatives from Guotai Junan and Zhonghui Life Insurance [1] - The meeting was categorized as a telephone conference [1] Group 2: Company Representatives - The meeting was hosted by the Board Secretary, Qian Yinghui [1] - Investor relations management included Zhang Yu and Yang Kexin [1] Group 3: Main Discussion Points - The primary focus was to understand the company's production and operational status [1]

Group 1: Company Overview - Yunnan Baiyao Group Co., Ltd. is engaged in the production and operation of medicinal products [1] - The investor relations activity was conducted via a telephone conference on January 23, 2026 [1] Group 2: Participants - Participants included representatives from Guotai Junan and Agricultural Bank of China [1] - Company representatives included securities affairs representative Li Mengjue and investor relations managers Zhang Yu and Yang Kexin [1] Group 3: Meeting Objectives - The main objective of the meeting was to understand the company's production and operational status [1]

Group 1: AI Empowerment and Digital Transformation - The company is implementing its digital development plan (2022-2026) by leveraging data and AI technologies across key segments of the supply chain, enhancing operational efficiency and business innovation [2] - The self-developed "Marketing Business Operation Platform" has been piloted in the pharmaceutical business group, improving order processing and cost accounting, leading to a 30% reduction in manual workload and saving 60,000 paper documents annually [3] - The "One Product, One Code Traceability Platform" has been developed for traditional Chinese medicine, providing digital identity for authentic medicinal materials [2] Group 2: Supply Chain and Operational Efficiency - The company has achieved 100% automation in settlement processes, reducing the cycle from 30 days to real-time [3] - The establishment of 90 standard processes and 60 management indicators supports business decision-making effectively [3] - The "Smart Cloud Medicine" platform and "One Product, One Chain" model have created a closed-loop system covering all aspects from resource management to payment, significantly improving supply chain collaboration and management [3] Group 3: Research and Development Progress - The tumor organ library and molecular marker research projects have yielded results published in Cancer Cell and Chinese Clinical Oncology journals [4] - The INR101 diagnostic nuclear medicine project has entered phase III clinical trials, with 32 research centers established and 60 subjects enrolled [5] - The INR102 therapeutic nuclear medicine project has received a clinical trial notification, with phase I trials initiated and 12 patients enrolled [6] Group 4: Dividend Distribution - For the 2024 fiscal year, the company will distribute a cash dividend of 11.85 CNY per 10 shares, totaling 2,164,310,537.44 CNY, which represents 90.09% of the net profit attributable to shareholders [7] - The total cash dividend for 2024, including a special dividend, amounts to 23.98 CNY per 10 shares, with a total of 4,278,661,722.00 CNY distributed [7] - In the first half of 2025, a cash dividend of 10.19 CNY per 10 shares will be distributed, totaling 1.818 billion CNY, representing 50.05% of the net profit for that period [7] Group 5: Online Sales Performance - The pharmaceutical business group has seen over a 20% increase in O2O sales in the first half of 2025, aided by online content marketing [8] - The company generated 2.54 billion CNY in GMV from e-commerce platforms, attracting 4.845 million visitors and converting 3.54 million consumers [9] - Yunnan Baiyao toothpaste holds the number one market share in the domestic channel for 2025, while the brand ranked first in Tmall for anti-hair loss shampoo during the "618" shopping festival [9]

Group 1: Company Growth Plans - The company aims to increase customer penetration in the domestic market and develop new clients while enhancing import substitution [2] - Plans to leverage existing overseas clients' reputation and the benefits of being publicly listed to expand into international markets, including traditional markets in Europe and the US, as well as emerging markets in BRICS countries, Southeast Asia, and Africa [2] Group 2: Industry Demand Trends - The demand for all-steel giant tires is closely linked to the mining industry's growth, with tire consumption costs accounting for approximately 24% of operational expenses in large open-pit mines [3] - Global active large open-pit mines total 1,615, with around 63,900 giant mining trucks, indicating a robust market for all-steel giant tires [3] - By 2027, the global production of all-steel giant tires is expected to reach 358,000 units [3] Group 3: Product Pricing and Lifespan - Average prices for all-steel giant tires from January to June 2025 are: - 49-inch: CNY 51,300 per unit - 51-inch: CNY 87,000 per unit - 57-inch: CNY 182,800 per unit - 63-inch: CNY 347,000 per unit [6] - The lifespan of all-steel giant tires varies significantly based on factors such as mineral type, climate, road conditions, and load [5] Group 4: Industry Barriers - High technical barriers exist due to the demanding nature of all-steel giant tire production, requiring extensive practical feedback and long development cycles [7] - Market barriers arise from mining companies' focus on safety and efficiency, making it difficult for new entrants to gain acceptance [7] - The industry is capital-intensive, with high expectations for supplier reliability and production scale [7] Group 5: Future Outlook and Market Dynamics - The company is optimistic about maintaining a healthy gross margin despite increasing competition and market capacity, attributing this to high technical barriers and a focus on replacing international brands [9] - The replacement market for giant mining tires is significantly larger than the original equipment market, as tire selection is primarily based on mining conditions and owner preferences [10] - The company employs a direct sales model, engaging directly with clients, including well-known domestic and international mining companies [10]

Group 1: Business Overview and Product Applications - The company focuses on providing advanced system solutions and lifecycle services in the energy and power sectors, with products including compressors and heat exchangers, covering a temperature range of -271°C to 200°C [3] - Products are widely used in various industries such as food processing, cold chain logistics, industrial refrigeration, commercial air conditioning, and energy recovery systems [3] - The company has developed innovative technologies for nuclear power applications, including cooling systems and heat recovery solutions, supporting multiple nuclear power stations in China [6][7] Group 2: Data Center and Cooling Systems - The company’s subsidiary, Dunham-Bush, provides cooling equipment for data centers, including variable frequency centrifugal chillers and integrated natural cooling systems, with successful projects in both domestic and international markets [4] - The proportion of centrifugal chillers, especially magnetic levitation types, is increasing in the IDC market, while the proportion of screw chillers is decreasing [6] - The company has established a global after-sales service system supported by overseas manufacturing bases [6] Group 3: Heat Recovery and Energy Management - The company’s heat management segment focuses on industrial heat pumps and has been recognized as a national-level specialized "little giant" enterprise, with 96 patents and 33 software copyrights [8] - The company’s technologies for waste heat recovery and high-temperature heat pumps are aligned with national carbon neutrality policies, providing long-term demand certainty [10] - The company’s absorption heat exchangers and other technologies have received multiple national awards and recognitions for their energy-saving capabilities [9] Group 4: Aerospace and Fusion Energy Applications - The company produces liquefaction units for aerospace fuels, including hydrogen and methane, and has developed a helium gas compressor for superconducting magnet cooling systems used in controlled nuclear fusion [11][12] - The helium gas compressor is recognized as a significant technological equipment project by the National Energy Administration, supporting major scientific research projects [11] Group 5: Financial Projections and Market Demand - The joint venture with Yantai Modern Ice Wheel Heavy Industry is projected to generate revenues of over 700 million in 2024 and approximately 1 billion in 2025, driven by strong market demand [7]

Company Overview - The company, Yinchuan Weili Transmission Technology Co., Ltd., focuses on the development and production of gearboxes, particularly wind power gearboxes, and has a significant growth trajectory [1]. Cost Optimization Strategies - **Technical Optimization**: Increased R&D investment to enhance product design, reducing material costs while maintaining output power and torque [2]. - **Smart Manufacturing**: The smart factory is in the ramp-up phase, aiming for a capacity of 1,500 units, which will lower production time and labor costs through automation and information management [2]. - **Supply Chain Efficiency**: Established a supplier evaluation system to ensure quality and cost-effectiveness, focusing on high-margin in-house production and low-margin outsourcing [2]. - **Operational Synergy**: Improved internal management to reduce order response times and expand market reach, which will lower unit operational costs as sales increase [2]. Employee Recruitment and Impact on Profitability - The company is proactively hiring for its smart factory, which may increase short-term costs but is expected to drive capacity and revenue growth in the long term [3]. Quality Control Measures - A dedicated quality assurance center has been established, implementing comprehensive quality management throughout the production cycle, including adherence to ISO9001 and IATF16949 standards [4]. Competitive Advantage from Smart Factory - The smart factory will enhance competitiveness by addressing market demands for larger and smarter wind turbines, improving production efficiency, and increasing revenue potential [4][5]. - Expected annual revenue increase in the hundreds of millions following the release of new production capacity, alongside improved financial metrics such as liquidity ratios [5]. Financing Progress - The company plans to raise up to 600 million CNY through a targeted A-share issuance to fund the smart factory and enhance working capital [5].

投资者关系活动记录表 证券代码：300969 证券简称：恒帅股份 宁波恒帅股份有限公司 编号：2026-003 投资者关系活动类 别 □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 □新闻发布会 □路演活动 □现场参观 其他（电话会议） 参与单位名称及人 员姓名 中信证券：李景涛、陈彦龙；民生加银：董士萱、刘霄汉 时间 2026 年 1 月 26 日 地点 公司会议室 上市公司接待人员 姓名 董事会秘书：廖维明 投资者关系活动主 要内容介绍 公司业务及经营情况交流 问题一：简单介绍下公司从汽车拓展到机器人领域的开拓情况 及进展情况？ 答：公司深耕汽车产业多年，不仅与核心客户构建了稳固且 良好的合作关系，在电机技术领域亦积淀了深厚实力，相关产 品在汽车客户中已树立良好口碑，加之汽车和人形机器人在产 业上高度重合，这些都为公司向机器人领域延伸奠定了坚实基 础，推动业务开拓工作进展顺利。 从技术层面而言，公司当前的电机产品在各项核心技术指标上 | 均已满足机器人客户的要求，为业务的进一步拓展提供了有力 | | --- | | 支撑。机器人产业存在巨大的发展机遇，该领域的拓展有望成 | | 为公司未来第三大增 ...